Literature DB >> 12819558

Circadian blood pressure regulation in hospitalized depressed patients and non-depressed comparison subjects.

Florian Lederbogen1, Christian Gernoth, Bettina Hamann, Anja Kniest, Isabella Heuser, Michael Deuschle.   

Abstract

BACKGROUND: Neuroendocrine dysregulation and disturbed sleep, frequently seen in major depression, may interfere with circadian blood pressure regulation. DESIGN AND METHODS: Using a portable device, 24 h blood pressure profiles were registered in 69 depressed in-patients and 26 hospitalized, non-depressed comparison subjects. The use of antihypertensive medication was considered to be indicative of known arterial hypertension. Mean systolic and diastolic blood pressure levels were compared between the group of depressed patients not taking antihypertensive medication and the healthy comparison subjects, both for the entire 24 h of measurement, and for the daytime and night-time periods. In a subgroup of patients, circadian blood pressure follow-up data were obtained after 5 weeks of antidepressant therapy.
RESULTS: Depressed patients not receiving antihypertensive medication (n=52) had higher mean 24 h systolic blood pressure levels than non-depressed comparison subjects (125.5+/-14.7 versus 119.6+/-13.3 mmHg, P<0.05). Subgroup analysis revealed that this difference could be almost exclusively attributed to patients on hypnotic medication; this subgroup also had a high day/night blood pressure change ('dip'). In depressed patients using antihypertensive agents (n=17), circadian blood pressure levels pointed to a suboptimal control of hypertension. In the subgroup with follow-up measurements, circadian blood pressure levels had not changed after 5 weeks of antidepressant therapy.
CONCLUSION: Circadian blood pressure monitoring identified a subgroup of depressed patients characterized by higher mean systolic blood pressure levels, the use of hypnotics and a high day/night blood pressure change.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819558     DOI: 10.1097/00126097-200304000-00003

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  2 in total

1.  The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients.

Authors:  Georgios Paslakis; Maria Gilles; Florian Lederbogen; Claudia Schilling; Barbara Scharnholz; Michael Deuschle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-30       Impact factor: 5.270

2.  The relationship between hypertension and anxiety or depression in Hong Kong Chinese.

Authors:  Bernard My Cheung; Thy Au; Sy Chan; Cm Lam; Sh Lau; Rp Lee; Sf Lee; Ws Lo; Ehf Sin; My Tang; Hh Tsang
Journal:  Exp Clin Cardiol       Date:  2005
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.